Stelios Andreou

Stelios Andreou is an experienced professional in the pharmaceuticals industry, currently serving as the Head of Sales for Rare Diseases & Epilepsy in Greece at UCB. They held various roles throughout their career, including co-owner and sales director at Atarvis S.A. & S. Andreou - S. Marselos G.P. and positions with companies like Johnson & Johnson and Novartis. Stelios has a solid educational background, holding a Bachelor of Business Administration and a Master of Business Administration specializing in Pharma. Their expertise encompasses sales, marketing, and strategic planning within the healthcare sector.